Phillipe Abreu

University of Colorado Anschutz Medical Campus

Papers

Total Citations

H-Index

About

Dr. Philippe Abreu is a leading voice in transplant nephrology, with a focused expertise in the intersection of obesity and kidney transplantation. His work critically re-examines long-standing clinical barriers, particularly the historical exclusion of patients with severe obesity from transplant candidacy. In his highly influential commentary, "Should Kidney Transplantation be Offered to Patients with Body Mass Index >40?" (2025), Abreu challenges outdated observational data from the 1990s and early 2000s that associated high BMI with increased perioperative risk. By synthesizing modern evidence, he argues for a more equitable, outcomes-based approach to patient selection, advocating that transplantation should not be categorically denied based on BMI alone. This contribution has already garnered significant attention within the transplant community, sparking necessary debate on access and surgical eligibility. Dr. Abreu’s research is reshaping clinical protocols, aiming to expand life-saving transplant access to a historically underserved population while maintaining rigorous safety standards. His work stands as a pivotal reference for clinicians and researchers re-evaluating weight-based exclusion criteria in solid organ transplantation.